HDL Therapeutics, Inc. (“HDL Therapeutics”), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy the Plasma Delipidation System (PDS-2™ System) for reducing coronary atheroma in patients with homozygous familial hypercholesterolemia (HoFH), has signed a definitive merger agreement…
Second-Quarter 2023 Revenues of $12.7 Billion– Expected Decline in Paxlovid and Comirnaty(1) Revenues Drove 53% Operational Decrease in SecondQuarter 2023 Revenues– Second-Quarter 2023 Revenues from Comirnaty(1) and Paxlovid of $1.6 Billion– Excluding Contributions from Comirnaty(1) and Paxlovid, Revenues Grew 5%…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for ERVEBO, which is now indicated for the prevention of disease caused…
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents per share on the Company’s capital stock, payable on September 5, 2023, to shareholders of record as of August 14, 2023. This is a 2-cent, or 5.3%, increase…
Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it has been named to Fortune’s “Global 500” for 2023, the annual ranking of the top 500 companies worldwide by total revenue. Centene first made the…
McKesson Medical-Surgical, an affiliate of the McKesson Corporation, will participate as a silver sponsor of the National Association of Community Health Centers National Health Center Week 2023 (NHCW) Aug. 6-12. The theme of NHCW 2023 is “Community Health Centers: The…
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the third quarter of fiscal 2023 ended June 30, 2023. “We…
Owens & Minor, Inc. (NYSE: OMI)today reported financial results for the second quarter ended June 30, 2023. Second Quarter Key Highlights: “The second quarter of 2023 shows a continuation of our Patient Direct segment’s exceptional performance, with another quarter of…
TigerConnect, healthcare’s most trusted clinical collaboration platform, today announced it has been named a Leader in the 2023 Gartner Magic Quadrant for Clinical Communication and Collaboration (CC&C). The evaluation was based on inclusion criteria that included platforms’ competitive product offerings…
Owens & Minor, Inc. (NYSE: OMI)today reported financial results for the second quarter ended June 30, 2023. Second Quarter Key Highlights: “The second quarter of 2023 shows a continuation of our Patient Direct segment’s exceptional performance, with another quarter of…
Tivic Health® Systems, Inc. (“Tivic”, “Company”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the pricing of its previously announced public offering of 33,173,000 shares of its common stock at a public offering price…
Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced the U.S. Food and Drug Administration (FDA) approved ZURZUVAETM (zuranolone) 50 mg for adults with postpartum depression (PPD). ZURZUVAE is the first and only oral, once-daily, 14-day treatment that can provide rapid…